Michael H. Kroll, MD

    Michael H. Kroll, MD

    Professor of Medicine, Chief of the Section of Benign Hematology University of Texas MD Anderson Cancer Center

    You Make the Call

    • Should I have concerns about using an oral thrombin inhibitor in a patient with recurrent DVT? Sunday, February 1st, 2015

      Michael H. Kroll, MDProfessor of Medicine, Chief of the Section of Benign Hematology University of Texas MD Anderson Cancer Center This month, Michael H. Kroll, MD, advises on switching a patient with a history of deep-vein thrombosis (DVT) from warfarin to an oral thrombin inhibitor. CLINICAL DILEMMA A 50-year-old patient who is currently on warfarin for [...]

    back to top
    SHARE